Dr. Mike Cusnir, M.D

NPI: 1962490631
Total Payments
$297,209
2024 Payments
$20,146
Companies
102
Transactions
2,911
Medicare Patients
2,818
Medicare Billing
$395,498

Payment Breakdown by Category

Other$145,488 (49.0%)
Consulting$53,794 (18.1%)
Food & Beverage$50,754 (17.1%)
Travel$45,609 (15.3%)
Education$1,565 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $75,488 44 25.4%
Honoraria $70,000 31 23.6%
Consulting Fee $53,794 24 18.1%
Food and Beverage $50,754 2,657 17.1%
Travel and Lodging $45,609 125 15.3%
Education $1,565 30 0.5%

Top Paying Companies

Company Total Records Latest Year
Sirtex Medical Inc $158,972 213 $0 (2024)
Genentech USA, Inc. $23,850 175 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $18,199 93 $0 (2024)
Ipsen Biopharmaceuticals, Inc $12,241 41 $0 (2024)
Lilly USA, LLC $11,849 45 $0 (2024)
Eisai Inc. $8,034 66 $0 (2024)
SEAGEN INC. $7,783 38 $0 (2024)
AstraZeneca Pharmaceuticals LP $7,665 153 $0 (2024)
Celgene Corporation $4,663 152 $0 (2024)
PFIZER CHILE S.A. $4,311 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $20,146 379 Sirtex Medical Inc ($5,200)
2023 $31,039 324 Sirtex Medical Inc ($10,500)
2022 $35,125 304 Sirtex Medical Inc ($21,191)
2021 $28,912 302 Sirtex Medical Inc ($15,294)
2020 $14,378 259 Sirtex Medical Inc ($6,000)
2019 $34,968 459 Sirtex Medical Inc ($24,994)
2018 $84,115 498 Sirtex Medical Inc ($54,124)
2017 $48,526 386 Sirtex Medical Inc ($21,669)

All Payment Transactions

2,911 individual payment records from CMS Open Payments — Page 1 of 117

Date Company Product Nature Form Amount Type
12/22/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $32.10 General
Category: Oncology
12/20/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $15.15 General
Category: Oncology
12/19/2024 BeiGene USA, Inc. BRUKINSA (Drug) Food and Beverage In-kind items and services $25.83 General
Category: Oncology
12/19/2024 Novartis Pharmaceuticals Corporation PLUVICTO (Drug) Food and Beverage In-kind items and services $23.05 General
Category: Oncology
12/18/2024 Celgene Corporation ONUREG (Drug) Food and Beverage Cash or cash equivalent $34.91 General
Category: Oncology
12/17/2024 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $28.67 General
Category: Oncology
12/17/2024 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $18.21 General
Category: Hematology/Oncology
12/16/2024 ABBVIE INC. ELAHERE (Drug) Food and Beverage In-kind items and services $29.45 General
Category: ONCOLOGY
12/12/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $16.25 General
Category: Hematology
12/11/2024 PFIZER INC. PADCEV (Biological) Food and Beverage In-kind items and services $13.03 General
Category: Oncology
12/10/2024 Karyopharm Therapeutics Inc. XPOVIO (Drug) Food and Beverage In-kind items and services $15.98 General
Category: Oncology
12/09/2024 Celgene Corporation Food and Beverage Cash or cash equivalent $27.94 General
12/05/2024 Takeda Pharmaceuticals U.S.A., Inc. NINLARO (Drug) Food and Beverage In-kind items and services $21.90 General
Category: ONCOLOGY
12/05/2024 AstraZeneca Pharmaceuticals LP CALQUENCE (Drug) Food and Beverage In-kind items and services $11.48 General
Category: Oncology
12/04/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $19.93 General
Category: Oncology
12/04/2024 SpringWorks Therapeutics, Inc. OGSIVEO (Drug) Food and Beverage In-kind items and services $18.57 General
Category: DESMOID TUMORS
12/03/2024 AstraZeneca Pharmaceuticals LP LYNPARZA (Drug) Food and Beverage In-kind items and services $24.08 General
Category: Oncology
12/03/2024 Tempus AI, Inc XT CDX (Device) Food and Beverage In-kind items and services $2.37 General
Category: NONE
12/02/2024 ABBVIE INC. ELAHERE (Drug) Food and Beverage In-kind items and services $31.62 General
Category: ONCOLOGY
12/01/2024 Deciphera Pharmaceuticals Inc. QINLOCK (Drug), TGCT Food and Beverage In-kind items and services $24.61 General
Category: ONCOLOGY
11/27/2024 EMD Serono, Inc. Food and Beverage Cash or cash equivalent $23.04 General
11/26/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $28.50 General
Category: Hematology
11/26/2024 Astellas Pharma US Inc Xospata (Drug) Food and Beverage In-kind items and services $22.50 General
Category: Oncology
11/26/2024 GENZYME CORPORATION ENJAYMO (Biological) Food and Beverage In-kind items and services $19.88 General
Category: Hematology
11/25/2024 BeiGene USA, Inc. TEVIMBRA (Drug) Consulting Fee Cash or cash equivalent $1,375.00 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 625 1,502 $289,230 $88,281
2022 4 575 1,543 $283,195 $88,310
2021 5 755 1,915 $357,497 $111,841
2020 6 863 2,139 $418,558 $107,066
Total Patients
2,818
Total Services
7,099
Medicare Billing
$395,498
Procedure Codes
35

All Medicare Procedures & Services

35 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 199 609 $100,485 $31,024 30.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 186 483 $79,695 $24,247 30.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 63 135 $34,020 $10,935 32.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 64 126 $31,752 $10,501 33.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 47 83 $18,924 $5,419 28.6%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 28 28 $12,124 $3,135 25.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 14 14 $6,062 $1,524 25.1%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2023 12 12 $3,084 $757.07 24.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 12 12 $3,084 $740.20 24.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 205 649 $107,085 $34,597 32.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 199 594 $98,010 $30,578 31.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 53 96 $24,192 $7,952 32.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 45 107 $24,396 $6,492 26.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 45 69 $17,388 $5,556 32.0%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 15 15 $6,495 $1,680 25.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 13 13 $5,629 $1,456 25.9%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 236 802 $132,330 $42,979 32.5%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 257 685 $113,025 $36,066 31.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 55 149 $33,972 $9,146 26.9%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 66 95 $23,940 $7,682 32.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 47 90 $22,680 $7,640 33.7%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 25 25 $10,825 $2,800 25.9%
99203 New patient outpatient visit, total time 30-44 minutes Facility 2021 31 31 $7,967 $2,147 26.9%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 17 17 $7,361 $1,950 26.5%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 21 21 $5,397 $1,430 26.5%

About Dr. Mike Cusnir, M.D

Dr. Mike Cusnir, M.D is a Specialist healthcare provider based in Miami Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962490631.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mike Cusnir, M.D has received a total of $297,209 in payments from pharmaceutical and medical device companies, with $20,146 received in 2024. These payments were reported across 2,911 transactions from 102 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($75,488).

As a Medicare-enrolled provider, Cusnir has provided services to 2,818 Medicare beneficiaries, totaling 7,099 services with total Medicare billing of $395,498. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Other Specialties Hematology & Oncology
  • Location Miami Beach, FL
  • Active Since 10/07/2005
  • Last Updated 07/19/2014
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1962490631

Products in Payments

  • SIR-Spheres Microspheres (Device) $158,972
  • Avastin (Biological) $21,675
  • Stivarga (Drug) $17,708
  • Onivyde (Drug) $11,004
  • Lenvima (Drug) $7,842
  • TUKYSA (Drug) $7,310
  • BRAFTOVI (Drug) $5,356
  • CYRAMZA (Drug) $3,787
  • CALQUENCE (Drug) $3,144
  • IMFINZI (Biological) $2,405
  • Rituxan (Drug) $1,800
  • KEYTRUDA (Biological) $1,620
  • LONSURF (Drug) $1,545
  • XTANDI (Drug) $1,526
  • TEVIMBRA (Drug) $1,394
  • REBLOZYL (Biological) $1,206
  • IMBRUVICA (Drug) $1,068
  • BRUKINSA (Drug) $1,064
  • OPDIVO (Biological) $1,017
  • ERLEADA (Drug) $994.40

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Miami Beach